Matthew Perry’s Death Investigation ‘Will Definitely Uncover A-List Drug Involvement’ as Hollywood Crackdown Sparks Anxiety Among Stars

The investigation into Matthew Perry’s death is expected to reveal even more startling details.

A law enforcement expert informed Sydtomarket.net that the extensive case will “definitely” expose A-list celebrities involved in drug-related crimes as prosecutors delve into Hollywood’s hidden underworld.

The five arrests linked to Perry’s death underscore a national drug crackdown and highlight the rising popularity of ketamine, which has gained acceptance as a mental health treatment.

Tracy Walder, a former CIA officer and FBI special agent, noted that ketamine has increasingly infiltrated the black market since its medical use became more widespread. She has no doubt that Perry’s death will bring more high-profile ketamine users into the spotlight.

Walder stated, “I absolutely believe there are high-profile individuals using this drug who might be arrested as a result.”

The most incriminating information, according to Walder, could come from “ketamine queen” Jasveen Sangha, who allegedly sold Perry the supply that led to his overdose on October 28, 2023. Walder believes that if Sangha were offered a plea deal, she could provide crucial details about her clients and suppliers, potentially leading to further arrests.

Erik Fleming, another defendant in the case, reportedly told Perry’s assistant that Sangha “only deals with high-end celebrities.” Perry allegedly spent $11,000 on 50 vials of ketamine from Sangha and Fleming in the weeks before his death.

Sangha is accused of running a sophisticated underground operation from her North Hollywood home, serving as a hub for drug distribution, manufacturing, and storage. She has pleaded not guilty to distributing ketamine resulting in death and faces a potential life sentence if convicted.

Walder believes that due to the severity of the charges, Sangha may be compelled to provide significant information about her network in exchange for a reduced sentence.

Three other co-defendants, including Fleming, disgraced doctor Mark Chavez, and Perry’s assistant Kenneth Iwamasa, have already agreed to plead guilty and cooperate with investigators in exchange for lighter sentences. Despite this, Walder noted that these deals would still likely involve substantial jail time.

Walder is confident that all key participants in Perry’s death have been identified and that the digital evidence against them is strong enough for conviction. She also highlighted the growing public frustration with the increasing number of fentanyl and drug overdose deaths, which has prompted greater pressure on the government to take action.

Recently, a judge granted Sangha’s request to delay the case, setting a new trial date for March 4, 2025.